Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
O
← Scanner

ABBVAbbVie Inc.

Healthcare·Drug Manufacturers—General·NYSE·Mkt cap $320.00B
$248.02
$0.06 (+0.02%) today
IEX feed · not consolidated
Last updated Jul 14, 10:09 AM
66/100 Opportunity
24Risk
70Momentum
56Pullback
75Quality
68Valuation
93Trend
Price & History (up to 5 years)
2025-09-11 → 2026-09-11
Low 195.98— support · — resistanceHigh 266.10
Technical Indicators
RSI (14)60.3
MACD hist-0.61
ATR (14)6.13
SMA 20241.50
SMA 50224.77
SMA 200220.80
Rel volume0.6x
Boll upper268.62
Boll lower214.38
52w high261.58
52w low180.39
5y high261.58
5y low88.49
Hist. vol26%
Max drawdown-17%
Sideways RangeBuy WatchWait for ConfirmationEntry: Pullback Watch
Company QualityHigh Quality
Revenue growth+8.0%
Earnings growth+10.0%
Profit margin+16.0%
ROE+20.0%
Debt/Equity0.60
Free cash flow—
P/E22.0
Fwd P/E18.0
P/S4.0
P/B4.5
Div yield+1.5%

AbbVie Inc. — Drug Manufacturers—General company in the Healthcare sector.

Decision SummaryInternal Rule-Based Analysis
Current Rating
Neutral / Needs Confirmation
Opportunity Score
66/100
Risk Level
Low
Best Action
Add to watchlist and monitor for confirmation

Why: ABBV is trading near recent levels (+0.0% today). Overall, the company is fundamentally strong. It is in a longer-term sideways range. Price is holding above key moving averages with constructive structure. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality75
Historical Context58
Valuation68
Trend93
Momentum70
Pullback56
News Sentiment50
Business Move50
Sector Strength55
Risk/Reward57
Entry Timing55
Sell Risk30
Risk24

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent NewsLive headlines

Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.